Ionis Pharmaceuticals Inc (IONS)
33.94
-1.46
(-4.11%)
USD |
NASDAQ |
Nov 21, 16:00
33.94
0.00 (0.00%)
After-Hours: 20:00
Ionis Pharmaceuticals Profit Margin (Quarterly): -105.0% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -105.0% |
| June 30, 2024 | -29.42% |
| March 31, 2024 | -119.5% |
| December 31, 2023 | -2.85% |
| September 30, 2023 | -102.2% |
| June 30, 2023 | -45.27% |
| March 31, 2023 | -95.25% |
| December 31, 2022 | -34.52% |
| September 30, 2022 | -29.41% |
| June 30, 2022 | -78.58% |
| March 31, 2022 | -45.92% |
| December 31, 2021 | 51.05% |
| September 30, 2021 | -61.96% |
| June 30, 2021 | -64.31% |
| March 31, 2021 | -80.52% |
| December 31, 2020 | -122.1% |
| September 30, 2020 | -15.28% |
| June 30, 2020 | -17.61% |
| March 31, 2020 | -29.71% |
| December 31, 2019 | 34.11% |
| September 30, 2019 | 15.58% |
| June 30, 2019 | -0.53% |
| March 31, 2019 | 28.41% |
| December 31, 2018 | |
| September 30, 2018 | -3.14% |
| Date | Value |
|---|---|
| June 30, 2018 | -34.27% |
| March 31, 2018 | -0.98% |
| December 31, 2017 | -1.74% |
| September 30, 2017 | -2.21% |
| June 30, 2017 | -2.75% |
| March 31, 2017 | 7.74% |
| December 31, 2016 | 27.89% |
| September 30, 2016 | 6.63% |
| June 30, 2016 | -147.8% |
| March 31, 2016 | -170.6% |
| December 31, 2015 | -138.5% |
| September 30, 2015 | -72.83% |
| June 30, 2015 | 29.60% |
| March 31, 2015 | -26.71% |
| December 31, 2014 | 36.59% |
| September 30, 2014 | -60.54% |
| June 30, 2014 | -21.17% |
| March 31, 2014 | -111.1% |
| December 31, 2013 | -57.46% |
| September 30, 2013 | -104.2% |
| June 30, 2013 | -26.58% |
| March 31, 2013 | -3.86% |
| December 31, 2012 | -13.27% |
| September 30, 2012 | -324.4% |
| June 30, 2012 | -2.55% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-122.1%
Minimum
Dec 2020
51.05%
Maximum
Dec 2021
-49.72%
Average
-45.59%
Median
Profit Margin (Quarterly) Benchmarks
| Biogen Inc | 15.76% |
| Alnylam Pharmaceuticals Inc | -22.27% |
| Biomarin Pharmaceutical Inc | 14.22% |
| Amicus Therapeutics Inc | -4.75% |
| Arbutus Biopharma Corp | -1.47K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -93.21% |
| Return on Assets | -12.41% |
| Return on Invested Capital | -21.57% |
| Gross Profit Margin (Quarterly) | 99.20% |
| Operating Margin (Quarterly) | -111.1% |
| Return on Net Operating Assets | -108.6% |